Termination of Essential Plan Health Coverage in New York
Learn about the termination of Essential Plan health coverage in New York, impacting 500,000 residents. Discover support and options available now.
Senate Votes on Medicare Pilot Program Dispute Involving AI
A Senate vote may halt a Medicare pilot program using AI for claim reviews, sparking concerns about care denial and oversight quality.
Sick of It! Fix Health Care Now Campaign Launch
Join the 'Sick of It! Fix Health Care Now' campaign as it addresses health care costs, Medicaid funding, and advocates for valuable reform across the nation.
Understanding the LEAD ACO Model and Its Impact on Medicare's Future
Discover how the LEAD ACO model reshapes Medicare by enhancing accountability in care delivery and improving financial outcomes for providers.
Proposed Reforms to Medicare's Physician Payment and Value-Based Care Programs
Learn about CMS's proposed reforms aimed at modernizing Medicare's physician payment processes and enhancing value-based care for improved patient outcomes.
California's 2026-27 Budget: Impact on Medicaid and Medi-Cal
Explore California's 2026-27 budget's implications for Medi-Cal and Medicaid, focusing on funding, policy changes, and essential health reforms.
New Medicaid Work Requirements Impact Farmworkers
Learn how new Medicaid work requirements affect farmworkers' access to health coverage and the challenges posed by increased bureaucracy and regulations.
Medicare GLP-1 Bridge Program: Key Insights and Implications
Discover how the new Medicare GLP-1 Bridge program impacts coverage for millions, refreshing access to critical medications and influencing federal costs.
New Medicare Initiative for Anti-Obesity Medications—A Step Forward
Discover how a new Medicare initiative expands access to anti-obesity medications, impacting senior healthcare costs and chronic disease management.
Eli Lilly's Growth Potential in GLP-1 Obesity Treatments
Discover how Eli Lilly is leveraging the GLP-1 Bridge program to enhance market access for obesity treatments, facing challenges, and driving growth in the pharmaceutical industry.